Kevin Haworth

Kevin Haworth currently serves as Associate Director of In Vivo Biology at Outpace Bio, following roles as Senior Scientist and In Vivo Team Lead. Prior experience includes working as Senior Scientist and In Vivo Group Lead at Zymeworks Inc., and Scientist II in Discovery Research at Nohla Therapeutics, where Kevin focused on gene editing technologies related to cell therapy. Earlier career stages included research positions at Fred Hutch and the University of Southern California, where Kevin concentrated on gene therapy for infections and genetic diseases, with a doctoral dissertation examining the interaction of HIV proteins with host cell factors. Kevin holds a PhD in Molecular Microbiology and Immunology from the Keck School of Medicine and a BS in Biochemistry and Molecular Biology from Colorado State University.